New hope for sufferers of age related eye disease
Washington: Scientists at Trinity College Dublin have made a major breakthrough which could help sufferers of the eye disease Age-Related Macular Degeneration (AMD), that can cause central blindness in sufferers.
The scientists found that a component of the immune system, 'IL-18', acts as a guardian of eyesight by suppressing the production of damaging blood vessels behind the retina at the back of the eye.
In addition, in pre-clinical models, it was shown that 'IL-18' can be administered in a non-invasive way, which could represent a major improvement on the current therapeutic options that are open to patients.
"We were initially concerned that IL-18 might cause damage to the sensitive cells of the retina, because it is typically linked to inflammation. But surprisingly we found that low doses had no adverse effects on the retina and yet still suppressed abnormal blood vessel growth," Assistant Professor in Immunology at Trinity, Sarah Doyle, who is the first author on the paper, said.
AMD is one of the most common forms of blindness in the aging population. The disease involves a loss of central vision, such that people suffering at advanced stages are unable to read, watch TV, drive, or use computers.
There are two forms of AMD: 'dry' and 'wet'. Dry AMD accounts for the majority of cases, but wet AMD causes over 90 percent of blindness associated with the disease.
In wet AMD, blood vessels underneath the retina begin to grow abnormally, which causes almost immediate central blindness. Because central vision accounts for almost all of our daytime visual acuity, wet AMD sufferers experience severe and profound day-to-day challenges.
Treatment options for wet AMD are currently limited to the end stages of the disease. Regular injections of antibodies must be made directly into the eye to mop up a problematic molecule termed 'VEGF'.
However, the Trinity scientists found that IL-18 directly inhibits VEGF production, and that it can work as effectively as the current treatment when administered via a non-invasive intravenous injection in pre-clinical settings.
The research is published online in the high-profile international journal, Science Translational Medicine.
More from India
More from World
More from Sports
More from Entertaiment
- DNA: Harmful chemicals found in Maggi, Nestle India still in denial mode
- CM Kejriwal shortlists 39 'unwanted' IAS officers in Delhi
- Rajasthan: Gujjars revive reservation agitation, block rail track
- DNA: Modi-led NDA govt's hits and misses in one year
- J Jayalalithaa sworn-in as Chief Minister of Tamil Nadu
- ISIS to buy first nuclear weapon from Pak?
- Dr Subhash Chandra Show: Aspiring for more than what you have!
- Mumbai: CCTV captures assailant with gun at Film City
- Mathura SSP receives death threat letter, message for PM Modi
- BJP now central pole of Indian politics: Arun Jaitley
- Maharashtra FDA sends Maggi noodles for lab testing
- See what can Maggi do to your health!
- Watch: Fast N Facts @ 7:30pm
- Delhi: Two killed in road accident in New Ashok Nagar
- Haridwar: Hotel Radisson Blu sealed for polluting Ganga
- PM Narendra Modi graces Digvijay Singh's son wedding reception
- Goa Board SSC Exam Results 2015 announced
- Rahul Gandhi to pressurise govt to act on one-rank-one-pension issue
- ISIS close to buying nuclear weapon from Pakistan?
- Manohar Parrikar visits forward areas along LoC, reviews security situation
- There will be no delay in appointing CIC, CVC: Jitendra Singh
- Credibility of Prime Minister's Office restored by BJP, says Arun Jaitley
- ISIS justifies raping slave girls, says Michelle Obama is 'worth $40'
- Arvind Kejriwal to highlight AAP govt's 100 days work on Monday
- 'Unhappy' Celina Jaitley asks Sunny Leone to move out?
- BJP's plan for one-year celebration: 200 big rallies, 5,000 public meetings
- Video of cops dancing with woman goes viral, inquiry ordered
- Heatwave leaves 153 dead in Telangana, Andhra Pradesh
- IPL 2015 Final: Mumbai Indians vs Chennai Super Kings - Preview
- Jayalalithaa returns as Tamil Nadu CM: As it happened